United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver Failure 26 January
United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors 22 January
United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference 05 January
